Wegovy: Novo Nordisk's Groundbreaking Weight Loss Pill Launches in the U.S.
Monday, 5 January 2026, 17:10
Wegovy Pill Launch: A New Era in Weight Loss Treatment
The introduction of Wegovy, produced by Novo Nordisk, represents a significant innovation in the fight against obesity. This pill form of their weight loss drug is now available in the U.S., making treatment more accessible for millions.
Details of Wegovy's Release
- Pricing: The starting price for self-paying patients is $149 per month.
- After mid-April, the cost for a 4 mg dose will increase to $199.
- The initial dose available is 1.5 mg.
According to Ed Cinca, senior vice president of marketing and patient solutions at Novo Nordisk, this new offering is a key step in providing effective treatment options for obesity.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.